Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A

This publication has 13 references indexed in Scilit:

• Prolonged bleeding-free period following prophylactic infusion of recombinant factor VIII reconstituted with pegylated liposomes
  Blood, 2006
• Effects of haemophilic arthropathy on health‐related quality of life and socio‐economic parameters
  Haemophilia, 2005
• Factor VIII efficient and specific non-covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy
  Thrombosis and Haemostasis, 2005
• Future directions of liposome- and immunoliposome-based cancer therapeutics
  Seminars in Oncology, 2004
• Consensus perspectives on prophylactic therapy for haemophilia: summary statement
  Haemophilia, 2003
• Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective
  Haemophilia, 2003
• A systematic review of the associations between dose regimens and medication compliance
  Clinical Therapeutics, 2001
• Barriers to compliance with prophylaxis therapy in haemophilia
  Haemophilia, 2001
• Pharmacokinetics of Coagulation Factors
  Clinical Pharmacokinetics, 2001
• Synovium in haemophilic arthropathy
  Haemophilia, 1998